UBTF and colorectal carcinoma: Another notable gene linked to oxaliplatin resistance and incorporated into one of the prognostic classifiers is UBTF. Our results indicate that higher expression of UBTF is associated with greater oxaliplatin sensitivity in vitro and improved prognosis in Stage II/III CRC patients.